Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Substrate interactions in the human type IIa sodium-phosphate cotransporter (NaPi-IIa).

Leila V Virkki1, Ian C Forster, Jürg Biber

  • 1Institute of Physiology, University of Zurich, Zurich, Switzerland. leilav@physiol.unizh.ch

American Journal of Physiology. Renal Physiology
|December 23, 2004
PubMed
Summary

The renal sodium-phosphate cotransporter (NaPi-IIa) uses a 3:1:1 Na+:Pi:charge stoichiometry, with phosphate (HPO42-) binding influenced by voltage and pH. Sodium binding precedes phosphate, modulating transporter orientation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Loss-of-Function KCNH2 Variants in Cardiac Arrhythmias, Seizures and the Risk of Sudden Unexpected Death in Epilepsy.

Journal of neurochemistry·2026
Same author

Org 34167 rescues voltage dependence of mutant channels and normalizes hyperexcitability in HCN1 epilepsy.

Epilepsia·2025
Same author

HCN2-Associated Neurodevelopmental Disorders: Data from Patients and Xenopus Cell Models.

Annals of neurology·2025
Same author

Different fluorescent labels report distinct components of spHCN channel voltage sensor movement.

The Journal of general physiology·2024
Same author

Mono and biallelic variants in <i>HCN2</i> cause severe neurodevelopmental disorders.

medRxiv : the preprint server for health sciences·2024
Same author

The Potential Antidepressant Compound Org 34167 Modulates HCN Channels Via a Novel Mode of Action.

Molecular pharmacology·2023

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Renal Physiology

Background:

  • The renal type IIa sodium-phosphate cotransporter (NaPi-IIa) is crucial for phosphate reabsorption.
  • Understanding its transport kinetics is vital for comprehending renal phosphate homeostasis.

Purpose of the Study:

  • To characterize the transport kinetics of the human NaPi-IIa cotransporter.
  • To elucidate the interplay between substrate binding, voltage, and pH in the NaPi-IIa transport cycle.

Main Methods:

  • Expression of human NaPi-IIa in Xenopus laevis oocytes.
  • Voltage-clamp electrophysiology to measure steady-state and pre-steady-state currents.
  • Isotope flux assays to quantify substrate uptake (32Pi, 22Na).

Main Results:

Related Experiment Videos

  • Established a Na+:Pi:charge stoichiometry of 3:1:1 for NaPi-IIa, with HPO4(2-) as the preferred phosphate species.
  • Demonstrated voltage-dependent HPO4(2-) affinity, modulated by pH and Na+ concentration.
  • Pre-steady-state analysis revealed sequential Na+ binding prior to Pi, influencing transporter orientation.

Conclusions:

  • Modified existing NaPi-II transport models to incorporate voltage-dependent HPO4(2-) binding.
  • Highlighted the role of protonation in modulating the initial Na+ binding step.
  • Provided key insights into the complex kinetic mechanism of renal sodium-phosphate cotransport.